Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tramadol controlled release - Nippon Zoki Pharmaceutical

Next Previous
Drug Profile

Tramadol controlled release - Nippon Zoki Pharmaceutical

Alternative Names: NZ-687; NZ-687-SR

Latest Information Update: 21 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nippon Zoki
  • Class Analgesics; Anisoles; Anti-inflammatories; Antidepressants; Antipyretics; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Opioid mu receptor agonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Cancer pain

Most Recent Events

  • 21 Dec 2021 Efficacy and safety data from a phase III trial in cancer pain released by Nippon-Zoki (JapicCTI-184143)
  • 30 Oct 2020 Nippon Zoki completes phase III trial in Cancer pain (Treatment-naive) in Japan (PO) (JapicCTI-184143)
  • 05 Oct 2018 Phase-III clinical trials in Cancer pain (Treatment-naive) in Japan (PO) (JapicCTI-184143)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top